skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Balloon-Expandable Stent Graft for Treating Uretero-Iliac Artery Fistula

Abstract

PurposeTo evaluate the safety, efficacy and outcome of percutaneous balloon-expandable covered stent graft placement for uretero-iliac artery fistula (UAF) treatment.MethodsThis retrospective study evaluated the single-center experience of percutaneous balloon-expandable covered stent graft placement (ADVANTA™, Atrium Hudson, NH, USA) in UAF. Data were obtained from a prospective institutional database. Patient follow-up included complications, symptoms recurrence and mortality rate.ResultsTen UAFs in eight patients (3 males; 5 females) with a mean age of 64.5 (35–77) years were identified. All patients had a history pelvic malignancy, extirpative surgery (n = 6), long-term ureteral stenting (n = 7) and pelvic radiation (n = 5). All procedures were completed successfully without complications. Thirty-day mortality rate was zero. At a median follow-up of 6 (1–60) months, one patient suffered recurrent hematuria requiring a secondary stent graft placement 26 months after the initial treatment. During follow-up, five patients died of the underlying disease (43, 66, 105, and 183 and 274 days after the last procedure).ConclusionPercutaneous balloon-expandable stent graft placement in UAF is a safe and effective treatment option. Implantation of stent grafts should be considered as treatment of choice in UAF.

Authors:
 [1];  [2];  [1];  [2];  [1]
  1. Philipps University, Department of Diagnostic and Interventional Radiology, Marburg University Hospital (Germany)
  2. Philipps University, Department of Urology and Pediatric Urology, Marburg University Hospital (Germany)
Publication Date:
OSTI Identifier:
22645173
Resource Type:
Journal Article
Resource Relation:
Journal Name: Cardiovascular and Interventional Radiology; Journal Volume: 40; Journal Issue: 6; Other Information: Copyright (c) 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; ARTERIES; ATRIA; BALLOONS; GRAFTS; MORTALITY; NEOPLASMS; PATIENTS; SAFETY; SURGERY; SYMPTOMS

Citation Formats

Guntau, Moritz, E-mail: guntau@med.uni-marburg.de, Hegele, Axel, Rheinheimer, Stephan, Hofmann, Rainer, and Mahnken, Andreas H.. Balloon-Expandable Stent Graft for Treating Uretero-Iliac Artery Fistula. United States: N. p., 2017. Web. doi:10.1007/S00270-017-1586-4.
Guntau, Moritz, E-mail: guntau@med.uni-marburg.de, Hegele, Axel, Rheinheimer, Stephan, Hofmann, Rainer, & Mahnken, Andreas H.. Balloon-Expandable Stent Graft for Treating Uretero-Iliac Artery Fistula. United States. doi:10.1007/S00270-017-1586-4.
Guntau, Moritz, E-mail: guntau@med.uni-marburg.de, Hegele, Axel, Rheinheimer, Stephan, Hofmann, Rainer, and Mahnken, Andreas H.. Thu . "Balloon-Expandable Stent Graft for Treating Uretero-Iliac Artery Fistula". United States. doi:10.1007/S00270-017-1586-4.
@article{osti_22645173,
title = {Balloon-Expandable Stent Graft for Treating Uretero-Iliac Artery Fistula},
author = {Guntau, Moritz, E-mail: guntau@med.uni-marburg.de and Hegele, Axel and Rheinheimer, Stephan and Hofmann, Rainer and Mahnken, Andreas H.},
abstractNote = {PurposeTo evaluate the safety, efficacy and outcome of percutaneous balloon-expandable covered stent graft placement for uretero-iliac artery fistula (UAF) treatment.MethodsThis retrospective study evaluated the single-center experience of percutaneous balloon-expandable covered stent graft placement (ADVANTA™, Atrium Hudson, NH, USA) in UAF. Data were obtained from a prospective institutional database. Patient follow-up included complications, symptoms recurrence and mortality rate.ResultsTen UAFs in eight patients (3 males; 5 females) with a mean age of 64.5 (35–77) years were identified. All patients had a history pelvic malignancy, extirpative surgery (n = 6), long-term ureteral stenting (n = 7) and pelvic radiation (n = 5). All procedures were completed successfully without complications. Thirty-day mortality rate was zero. At a median follow-up of 6 (1–60) months, one patient suffered recurrent hematuria requiring a secondary stent graft placement 26 months after the initial treatment. During follow-up, five patients died of the underlying disease (43, 66, 105, and 183 and 274 days after the last procedure).ConclusionPercutaneous balloon-expandable stent graft placement in UAF is a safe and effective treatment option. Implantation of stent grafts should be considered as treatment of choice in UAF.},
doi = {10.1007/S00270-017-1586-4},
journal = {Cardiovascular and Interventional Radiology},
number = 6,
volume = 40,
place = {United States},
year = {Thu Jun 15 00:00:00 EDT 2017},
month = {Thu Jun 15 00:00:00 EDT 2017}
}